Stresses of a failing heart

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 9, 2003, Pages 1017-1019

  Kirshenbaum, Lorrie A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DAMAGE; DNA DAMAGE; EDITORIAL; GENE REPRESSION; GENETIC PREDISPOSITION; HEART CONTRACTION; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE;

MUS MUSCULUS;

EID: 0041328900     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00239-6     Document Type: Editorial

References (29)

1. Seta Y., Shan K., Bozkurt B., Oral H., Mann D.L. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail. 2:(3):1996;243-249.
2. Schwartz K., Chassagne C., Boheler K.R. The molecular biology of heart failure. J Am Coll Cardiol. 22:(4 Suppl A):1993;A30-A33.
3. Afzal N., Dhalla N.S. Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol. 262:(3 Pt 2):1992;H868-H874.
4. Schwartz K., Carrier L., Lompre A.M., Mercadier J.J., Boheler K.R. Contractile proteins and sarcoplasmic reticulum calcium-ATPase gene expression in the hypertrophied and failing heart. Basic Res Cardiol. 87:(Suppl 1):1992;285-290.
5. Hill M.F., Singal P.K. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol. 148:(1):1996;291-300.
6. Singal P.K., Kirshenbaum L.A. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol. 6:(2):1990;47-49.
7. Mercadier J.J., Lompre A.M., Swynghedauw B., Schwartz K. Plasticite du phenotype myocardique au cours de l'hypertrophie et de l'insuffisance cardiaques (Plasticity of myocardial phenotype during cardiac hypertrophy and failure). Bull Acad Natl M. 177:(6):1993;917-931.
8. Mercadier J.J., Lompre A.M., Duc P., Boheler K.R., Fraysse J.B., Wisnewsky C., et al. Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest. 85:(1):1990;305-309.
9. Brilla C.G., Rupp H. Myocardial collagen matrix remodeling and congestive heart failure. Cardiologia. 39:(12 Suppl 1):1994;389-393.
10. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B., et al. Bone marrow cells regenerate infarcted myocardium. Nature. 410:(6829):2001;701-705.
11. Anversa P. Myocyte apoptosis and heart failure [editorial]. Eur Heart J. 19:(3):1998;359-360.
12. Quaini F., Cigola E., Lagrasta C., Saccani G., Quaini E., Rossi C., et al. End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes. Circ Res. 75:1994;1050-1063.
13. Narula J., Haider N., Virmani R., DiSalvo T.G., Kolodgie F.D., Hajjar R.J., et al. Apoptosis in myocytes in end-stage heart failure [see comments]. New Engl J M. 335:(16):1996;1182-1189.
14. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest. 111:(10):2003;1497-1504.
15. Mann D.L., Young J.B. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest. 105:(3):1994;897-904.
16. Dibbs Z., Kurrelmeyer K., Kalra D., Seta Y., Wang F., Bozkurt B., et al. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physician. 111:(5):1999;423-428.
17. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol. 274:(3 Pt 2):1998;R577-R595.
18. Dibbs Z., Thornby J., White B.G., Mann D.L. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. J Am Coll Cardiol. 33:(7):1999;1935-1942.
19. Levine B., Kalman J., Mayer L., Fillit H.M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J M. 323:(4):1990;236-241.
20. Yokoyama T., Vaca L., Rossen R.D., Durante W., Hazarika P., Mann D.L. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 92:(5):1993;2303-2312.
21. Bozkurt B., Kribbs S.B., Clubb F.J. Jr, Michael L.H., Didenko V.V., Hornsby P.J., et al. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation. 97:(14):1998;1382-1391.
22. Kubota T., McTiernan C.F., Frye C.S., Slawson S.E., Lemster B.H., Koretsky A.P., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 81:(4):1997;627-635.
23. Beg A.A., Baltimore D. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death [see comments]. Science. 274:(5288):1996;782-784.
24. Mustapha S., Kirshner A., de Moissac D., Kirshenbaum L.A. A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes. Am J Physiol Heart Circ Physiol. 279:(3):2000;H939-H945.
25. de Moissac D., Mustapha S., Greenberg A.H., Kirshenbaum L.A. Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. J Biol Chem. 273:(37):1998;23946-23951.
26. Beg A.A., Baldwin A.S. Jr. Activation of multiple NF-kappa B/Rel DNA-binding complexes by tumor necrosis factor. Oncogene. 9:(5):1994;1487-1492.
27. Massaia M., Borrione P., Attisano C., Barral P., Beggiato E., Montacchini L., et al. Dysregulated Fas and Bcl-2 expression leading to enhanced apoptosis in T cells of multiple myeloma patients. Blood. 85:(12):1995;3679-3687. Kurrelmeyer K.M., Michael L.H., Baumgarten G., Taffet G.E., Peschon J.J., Sivasubramanian N., et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA. 97:(10):2000;5456-5461.
28. Kurrelmeyer K.M., Michael L.H., Baumgarten G., Taffet G.E., Peschon J.J., Sivasubramanian N., et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc Natl Acad Sci USA. 97:(10):2000;5456-5461.
29. Krown K.A., Page M.T., Nguyen C., Zechner D., Gutierrez V., Comstock K.L., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 98:(12):1996;2854-2865.